U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H26ClNO6
Molecular Weight 399.866
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ARBACLOFEN PLACARBIL

SMILES

CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C

InChI

InChIKey=JXTAALBWJQJLGN-KSSFIOAISA-N
InChI=1S/C19H26ClNO6/c1-11(2)17(24)26-18(12(3)4)27-19(25)21-10-14(9-16(22)23)13-5-7-15(20)8-6-13/h5-8,11-12,14,18H,9-10H2,1-4H3,(H,21,25)(H,22,23)/t14-,18-/m0/s1

HIDE SMILES / InChI
Arbaclofen (STX209, R-baclofen), a selective agonist of GABA-B receptors, has been investigated in clinical trials for the treatment of autism spectrum disorder ASD, phase II and for the treatment of patients with fragile X syndrome in phase III. As a result, the drug did not meet the primary outcome of improved social avoidance in FXS in either study. In spite of positive results in some children with ASD, further study will be needed to replicate and extend these initial findings. Arbaclofen has also been investigated in phase III clinical trials as a treatment for spasticity due to multiple sclerosis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors.
1997 Mar 20
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
2012 Sep 19
Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder.
2014
Patents

Sample Use Guides

5 mg BID to 15 mg TID
Route of Administration: Oral
Name Type Language
ARBACLOFEN PLACARBIL
INN   MI   USAN  
INN   USAN  
Official Name English
BENZENEPROPANOIC ACID, 4-CHLORO-.BETA.-(((((1S)-2-METHYL-1-(2-METHYL-OXOPROPOXY)PROPOXY)CARBONYL)AMINO)METHYL)-, (.BETA.R)-
Common Name English
(3R)-3-(4-Chlorophenyl)-4-[[[(1S)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy]carbonyl]amino]butanoic acid
Systematic Name English
XP-19986
Code English
arbaclofen placarbil [INN]
Common Name English
ARBACLOFEN PLACARBIL [USAN]
Common Name English
XP19986
Code English
ARBACLOFEN PLACARBIL [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2199
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C76088
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
DRUG BANK
DB08892
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID40233754
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
SMS_ID
300000034033
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
MERCK INDEX
m2028
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY Merck Index
USAN
SS-38
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
WIKIPEDIA
ARBACLOFEN PLACARBIL
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107312
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
INN
8861
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
PUBCHEM
11281011
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
CAS
847353-30-4
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
FDA UNII
W89H91R7VX
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY
MESH
C543531
Created by admin on Sat Dec 16 17:24:17 GMT 2023 , Edited by admin on Sat Dec 16 17:24:17 GMT 2023
PRIMARY